Flaxseed influences urinary lignan excretion in a dose-dependent manner in postmenopausal women
- PMID: 11045796
Flaxseed influences urinary lignan excretion in a dose-dependent manner in postmenopausal women
Abstract
Dietary estrogens, such as lignans, are similar in structure to endogenous sex steroid hormones and may act in vivo to alter hormone metabolism and subsequent cancer risk. The objective of this study was to examine the effect of dietary intake of a lignan-rich plant food (flaxseed) on urinary lignan excretion in postmenopausal women. This randomized, cross-over trial consisted of three 7-week feeding periods during which 31 healthy postmenopausal women, ages 52-82 years, consumed their habitual diets plus 0, 5, or 10 grams of ground flaxseed per day. Urine samples collected for 2 consecutive days during the last week of each feeding period were analyzed for lignan content (enterodiol, enterolactone, and matairesinol) by isotope dilution gas chromatography/mass spectrometry. Compared with the 0-gram flaxseed diet, consumption of 5 or 10 grams of flaxseed significantly increased excretion of enterodiol by 1,009 and 2,867 nmol/day, respectively; significantly increased excretion of enterolactone by 21,242 and 52,826 nmol/day, respectively; and significantly increased excretion of total lignans (enterodiol + enterolactone + matairesinol) by 24,333 and 60,640 nmol/day, respectively. Excretion of matairesinol was not significantly altered by flaxseed consumption. Consumption of flax, a significant source of dietary estrogens, in addition to their habitual diets increased excretion of enterodiol and enterolactone, but not matairesinol, in a dose-dependent manner in this group of postmenopausal women. Urinary excretion of lignan metabolites is a dose-dependent biomarker of flaxseed intake within the context of a habitual diet.
Similar articles
-
Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women.Nutr Cancer. 2001;39(1):58-65. doi: 10.1207/S15327914nc391_8. Nutr Cancer. 2001. PMID: 11588903 Clinical Trial.
-
Fecal lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder.Cancer Epidemiol Biomarkers Prev. 1995 Jun;4(4):353-8. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7655330
-
Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products.J Am Diet Assoc. 1995 May;95(5):545-51. doi: 10.1016/S0002-8223(95)00149-2. J Am Diet Assoc. 1995. PMID: 7722188 Clinical Trial.
-
Can the combination of flaxseed and its lignans with soy and its isoflavones reduce the growth stimulatory effect of soy and its isoflavones on established breast cancer?Mol Nutr Food Res. 2007 Jul;51(7):845-56. doi: 10.1002/mnfr.200600218. Mol Nutr Food Res. 2007. PMID: 17579892 Review.
-
Health effects with consumption of the flax lignan secoisolariciresinol diglucoside.Br J Nutr. 2010 Apr;103(7):929-38. doi: 10.1017/S0007114509992753. Epub 2009 Dec 15. Br J Nutr. 2010. PMID: 20003621 Review.
Cited by
-
A pilot study comparing the effect of flaxseed, aromatase inhibitor, and the combination on breast tumor biomarkers.Nutr Cancer. 2014;66(4):566-75. doi: 10.1080/01635581.2014.894097. Epub 2014 Mar 26. Nutr Cancer. 2014. PMID: 24669750 Free PMC article. Clinical Trial.
-
Effects of Flaxseed on Perimenopausal Symptoms: Findings From a Single-Blind, Randomized, Placebo-Controlled Study.Cureus. 2024 Sep 3;16(9):e68534. doi: 10.7759/cureus.68534. eCollection 2024 Sep. Cureus. 2024. PMID: 39364521 Free PMC article.
-
Nutritional Metabolomics and the Classification of Dietary Biomarker Candidates: A Critical Review.Adv Nutr. 2021 Dec 1;12(6):2333-2357. doi: 10.1093/advances/nmab054. Adv Nutr. 2021. PMID: 34015815 Free PMC article. Review.
-
Comparing the effects of dietary flaxseed and omega-3 Fatty acids supplement on cyclical mastalgia in Iranian women: a randomized clinical trial.Int J Family Med. 2014;2014:174532. doi: 10.1155/2014/174532. Epub 2014 Aug 13. Int J Family Med. 2014. PMID: 25197571 Free PMC article.
-
Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.Breast Cancer Res Treat. 2010 Jul;122(1):229-35. doi: 10.1007/s10549-009-0681-x. Epub 2009 Dec 22. Breast Cancer Res Treat. 2010. PMID: 20033482 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources